Skip to Content
  • Rank13
  • Previous Rank18
  • CEO
    Larry J. Merlo
  • Address
    1 CVS Dr., Woonsocket, RI 2895
  • Website
    info.cvscaremark.com

Boosted by the business woes of its chief competitor, CVS Caremark jumped five places this year to No. 13 on the Fortune 500. Sales shot up 14% in 2012, thanks in part to customers who defected from Walgreens, after that company’s contract with prescription benefits manager Express Scripts lapsed last year, which resulted in making prescriptions cheaper at CVS. The company also has expanded its own prescription benefits business — Medicare D and Managed Medicaid are growth areas. With its popular “MinuteClinic” service — customers can skip the doctor and get quick, in-store medical consultation — CVS is poised to benefit when changes expected with healthcare reform hit in 2014 (i.e., more insured patients in a world with too-few physicians).

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Key Financials

$ Millions% change
Revenues123,13314.3
Profits
3876.90
12
Assets65,912-
Total Shareholder Equity37,704-
Market Value (on March 29, 2013)67,703.4-

Profit as a % of

Profit Percent Sales67,703.4
Profit Percent Assets5.9
Profit Percent Shareholder Equity10.3

Earnings Per Share

Earnings Per Share3.03
EPS % Change (from 2012)17.9
EPS Change (5 year)9.6
EPS Change (10 year)13.2

Total Return to Investors

Total Return to Investors20.3
Total Return to Investors (5 year)5.2
Total Return to Investors (10 year)
15.50